Flinton Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$24K Hold
1,568
﹤0.01% 854
2019
Q2
$32K Hold
1,568
﹤0.01% 850
2019
Q1
$28K Hold
1,568
﹤0.01% 840
2018
Q4
$20K Buy
+1,568
New +$20K ﹤0.01% 828